Advertisement

Topics

Entasis Therapeutics Holdings Inc. Company Profile

09:18 EDT 23rd May 2018 | BioPortfolio


News Articles [1183 Associated News Articles listed on BioPortfolio]

Entasis Therapeutics And Zai Lab Announce Exclusive License Agreement

NewsCollaboration will facilitate enrollment of pivotal global Phase 3 trial of ETX2514 in combination with sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii infections.

Entasi partners ETX2514SUL with Zai Lab in APAC region

Entasis Therapeutics Holdings Inc. licensed Zai Lab Ltd. exclusive rights to develop and commercialize ETX2514SUL in Japan and certain other Asia-Pacific countries.

Entasis begins Phase I trial of ETX0282 and ETX0282CPDP to treat infections

Entasis Therapeutics has commenced a Phase I clinical trial evaluating ETX0282 in combination with ETX0282CPDP to treat infections caused by...Read More... The post Entasis begins Phase I trial of ETX...

Entasis Therapeutics Appoints David C. Hastings to Board of Directors

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the...

Deals this week: Odonate Therapeutics, China Reform Holdings, Denali Therapeutics

US-based therapeutics developer Odonate Therapeutics LLC plans to raise $182.57m through an initial public offering (IPO) of 6,762,000 shares of...Read More... The post Deals this week: Odonate Therap...

Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and ...

Collaboration will facilitate enrollment of pivotal global Phase 3 trial of ETX2514 in combination with sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii infect...

Zai gets Asia-Pacific license to Entasis' antibiotic combinations

Pernix Therapeutics Holdings, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 18022018] Prices from USD $350

Pernix Therapeutics Holdings, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Pernix Therapeutics Holdings, Inc. Mergers Acquisitions MA, Partnerships...

PubMed Articles [400 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Pig movements in France: Designing network models fitting the transmission route of pathogens.

Pathogen spread between farms results from interaction between the epidemiological characteristics of infectious agents, such as transmission route, and the contact structure between holdings. The obj...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Clinical Trials [144 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1656 Associated Companies listed on BioPortfolio]

Entasis Therapeutics Holdings Inc.

Entasis Therapeutics Inc.

Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patie...

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. ...

Pernix Therapeutics Holdings, Inc.

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company primarily focused on serving the needs of the pediatric marketplace. Commercially-proven branded product f...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

More Information about "Entasis Therapeutics Holdings Inc." on BioPortfolio

We have published hundreds of Entasis Therapeutics Holdings Inc. news stories on BioPortfolio along with dozens of Entasis Therapeutics Holdings Inc. Clinical Trials and PubMed Articles about Entasis Therapeutics Holdings Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Entasis Therapeutics Holdings Inc. Companies in our database. You can also find out about relevant Entasis Therapeutics Holdings Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record